Why Charter Hall, Collins Foods, Endeavour Group, & Telix are pushing higher

These ASX shares are ending the week strongly…

| More on:
two women jumping into the air

Image source: Getty Images

In late morning trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a positive note. At the time of writing, the benchmark index is up 0.25% to 7,294.5 points.

Four ASX shares climbing more than most today are listed below. Here’s why they are pushing higher:

Charter Hall Group (ASX: CHC)

The Charter Hall share price has climbed 2% to $15.54. This morning the property company provided an update on property revaluations and the resultant impact on its Funds Under Management (FUM). According to the release, the company’s FUM Platform will generate gross valuation increases of $3.3 billion, inclusive of $0.6 billion of development capex. This will result in forecast FUM rising to approximately $52 billion as at 30 June 2021, up $12 billion over the course of FY 2021.

Collins Foods Ltd (ASX: CKF)

The Collins Foods share price is up 2% to $12.77. This gain appears to have been driven by a broker note out of Morgans. According to the note, the broker has retained its add rating and lifted its price target by 17% to $13.38. The KFC restaurant operator is due to release its full year results next week and Morgans is expecting a strong result from the core Australian business.

Endeavour Group (ASX: EDV)

The Endeavour share price is up 7% to $6.46. Investors have been buying the drinks business following its spin-off from Woolworths Group Ltd (ASX: WOW) on Thursday. Endeavour operates a retail drinks network through Dan Murphy’s and BWS, and a portfolio of licensed hospitality venues.

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix share price has jumped 10% to $6.20. This is despite there being no news out of the biopharmaceutical company today. However, Telix has released a number of positive updates over the last few weeks that may have caught the eye of investors. This includes positive feedback from the US FDA relating to its prostate cancer imaging investigational product Illuccix.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

Motley Fool contributor James Mickleboro owns shares of Collins Foods Limited and TELIXPHARM DEF SET. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Collins Foods Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers